Literature DB >> 18361419

Transmission disequilibrium testing of the chromosome 15q11-q13 region in autism.

Soo-Jeong Kim1, Camille W Brune, Emily O Kistner, Susan L Christian, Eric H Courchesne, Nancy J Cox, Edwin H Cook.   

Abstract

Evidence implicates the serotonin transporter gene (SLC6A4) and the 15q11-q13 genes as candidates for autism as well as restricted repetitive behavior (RRB). We conducted dense transmission disequilibrium mapping of the 15q11-q13 region with 93 single nucleotide polymorphisms (SNPs) in 86 strictly defined autism trios and tested association between SNPs and autism using the transmission disequilibrium test (TDT). As exploratory analyses, parent-of-origin effects were examined using likelihood-ratio tests (LRTs) and genotype-phenotype associations for specific RRB using the Family-Based Association Test (FBAT). Additionally, gene-gene interactions between nominally associated 15q11-q13 variants and 5-HTTLPR, the common length polymorphism of SLC6A4, were examined using conditional logistic regression (CLR). TDT revealed nominally significant transmission disequilibrium between autism and five SNPs, three of which are located within close proximity of the GABA(A) receptor subunit gene clusters. Three SNPs in the SNRPN/UBE3A region had marginal imprinting effects. FBAT for genotype-phenotype relations revealed nominally significant association between two SNPs and one ADI-R subdomain item. However, both TDT and FBAT were not statistically significant after correcting for multiple comparisons. Gene-gene interaction analyses by CLR revealed additive genetic effect models, without interaction terms, fit the data best. Lack of robust association between the 15q11-q13 SNPs and RRB phenotypes may be due to a small sample size and absence of more specific RRB measurement. Further investigation of the 15q11-q13 region with denser genotyping in a larger sample set may be necessary to determine whether this region confers risk to autism, indicated by association, or to specific autism phenotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18361419      PMCID: PMC4095800          DOI: 10.1002/ajmg.b.30733

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  70 in total

1.  Methods for detection of parent-of-origin effects in genetic studies of case-parents triads.

Authors:  C R Weinberg
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  A genomic screen of autism: evidence for a multilocus etiology.

Authors:  N Risch; D Spiker; L Lotspeich; N Nouri; D Hinds; J Hallmayer; L Kalaydjieva; P McCague; S Dimiceli; T Pitts; L Nguyen; J Yang; C Harper; D Thorpe; S Vermeer; H Young; J Hebert; A Lin; J Ferguson; C Chiotti; S Wiese-Slater; T Rogers; B Salmon; P Nicholas; P B Petersen; C Pingree; W McMahon; D L Wong; L L Cavalli-Sforza; H C Kraemer; R M Myers
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 3.  Genetics of childhood disorders: XV. Prader-Willi syndrome: genes, brain, and behavior.

Authors:  M W State; E M Dykens
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-06       Impact factor: 8.829

4.  Autistic symptoms among children and young adults with isodicentric chromosome 15.

Authors:  C Wolpert; M A Pericak-Vance; R K Abramson; H H Wright; M L Cuccaro
Journal:  Am J Med Genet       Date:  2000-02-07

5.  Implementing a unified approach to family-based tests of association.

Authors:  N M Laird; S Horvath; X Xu
Journal:  Genet Epidemiol       Date:  2000       Impact factor: 2.135

Review 6.  Three probands with autistic disorder and isodicentric chromosome 15.

Authors:  C M Wolpert; M M Menold; M P Bass; M B Qumsiyeh; S L Donnelly; S A Ravan; J M Vance; J R Gilbert; R K Abramson; H H Wright; M L Cuccaro; M A Pericak-Vance
Journal:  Am J Med Genet       Date:  2000-06-12

7.  Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder.

Authors:  E R Martin; M M Menold; C M Wolpert; M P Bass; S L Donnelly; S A Ravan; A Zimmerman; J R Gilbert; J M Vance; L O Maddox; H H Wright; R K Abramson; G R DeLong; M L Cuccaro; M A Pericak-Vance
Journal:  Am J Med Genet       Date:  2000-02-07

8.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

9.  Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study.

Authors:  A Philippe; M Martinez; M Guilloud-Bataille; C Gillberg; M Råstam; E Sponheim; M Coleman; M Zappella; H Aschauer; L Van Maldergem; C Penet; J Feingold; A Brice; M Leboyer; L van Malldergerme
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

10.  Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy.

Authors:  E M Dykens; S B Cassidy; B H King
Journal:  Am J Ment Retard       Date:  1999-01
View more
  13 in total

Review 1.  Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics.

Authors:  Suma Jacob; Angeli Landeros-Weisenberger; James F Leckman
Journal:  Autism Res       Date:  2009-12       Impact factor: 5.216

2.  Glutathione pathway gene variation and risk of autism spectrum disorders.

Authors:  Katherine Bowers; Qing Li; Joseph Bressler; Dimitrios Avramopoulos; Craig Newschaffer; M Daniele Fallin
Journal:  J Neurodev Disord       Date:  2011-03-05       Impact factor: 4.025

3.  GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.

Authors:  J L Silverman; M C Pride; J E Hayes; K R Puhger; H M Butler-Struben; S Baker; J N Crawley
Journal:  Neuropsychopharmacology       Date:  2015-03-10       Impact factor: 7.853

4.  Human serum transferrin: is there a link among autism, high oxalate levels, and iron deficiency anemia?

Authors:  Ashley N Luck; Cedric E Bobst; Igor A Kaltashov; Anne B Mason
Journal:  Biochemistry       Date:  2013-11-08       Impact factor: 3.162

5.  Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population.

Authors:  Yasuhisa Fukuo; Taro Kishi; Tomo Okochi; Tsuyoshi Kitajima; Tomoko Tsunoka; Takenori Okumukura; Yoko Kinoshita; Kunihiro Kawashima; Yoshio Yamanouchi; Wakako Umene-Nakano; Hiroshi Naitoh; Toshiya Inada; Reiji Yoshimura; Jun Nakamura; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2010-05-14       Impact factor: 3.843

6.  Single nucleotide polymorphisms predict symptom severity of autism spectrum disorder.

Authors:  Yun Jiao; Rong Chen; Xiaoyan Ke; Lu Cheng; Kangkang Chu; Zuhong Lu; Edward H Herskovits
Journal:  J Autism Dev Disord       Date:  2012-06

7.  Association of MET with social and communication phenotypes in individuals with autism spectrum disorder.

Authors:  Daniel B Campbell; Dana Warren; James S Sutcliffe; Evon Batey Lee; Pat Levitt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

8.  Interaction between GSTT1 and GSTP1 allele variants as a risk modulating-factor for autism spectrum disorders.

Authors:  Mohammad H Rahbar; Maureen Samms-Vaughan; Jianzhong Ma; Jan Bressler; Katherine A Loveland; Manouchehr Hessabi; Aisha S Dickerson; Megan L Grove; Sydonnie Shakespeare-Pellington; Compton Beecher; Wayne McLaughlin; Eric Boerwinkle
Journal:  Res Autism Spectr Disord       Date:  2015-04-01

9.  Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray.

Authors:  Lu Cheng; Qinyu Ge; Pengfeng Xiao; Beili Sun; Xiaoyan Ke; Yunfei Bai; Zuhong Lu
Journal:  Int J Mol Sci       Date:  2009-06-02       Impact factor: 6.208

10.  Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism.

Authors:  R J Delahanty; J Q Kang; C W Brune; E O Kistner; E Courchesne; N J Cox; E H Cook; R L Macdonald; J S Sutcliffe
Journal:  Mol Psychiatry       Date:  2009-11-24       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.